CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) has 20 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 18 sales totalling $4.6M. Most recent filing: Sept. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 18, 2026 filed Sept. 17, 2026 | Reynoso Jamie L. CEO, Medicare Advantage | −$8,760 | 1,921 | −0% | Yes | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 16, 2026 | OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER | −$14,709 | 3,170 | −1% | Yes | |
|
|
||||||
| Sept. 16, 2026 filed Sept. 15, 2026 | Wai Conrad CEO, Counterpart Health | −$1,416,000 | 300,000 | −20% | Yes | |
|
|
||||||
| Sept. 15, 2026 | Soares Karen Chief Legal Officer | −$32,724 | 6,846 | −0% | Yes | |
|
|
||||||
| Sept. 15, 2026 | Reynoso Jamie L. CEO, Medicare Advantage | −$44,325 | 9,273 | −0% | Yes | |
|
|
||||||
Showing the 5 most recent of 20 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free